News – Page 2 – www.brainwork.md

18th September 2020

Ageing in multiple sclerosis – what do we know?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-Ageing-in-multiple-sclerosis-–-what-do-we-know.png 2846 1601 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 18th September 2020 23rd September 2020

“Ageing comes with many issues in multiple sclerosis (MS): progression, comorbidities, cognition problems and response to treatment”, Pierre Duquette (Department of Neuroscience, University of Montreal, Canada), the chair of the…

Anna Stelling, PhD
0
0

18th September 2020

How to promote remyelination in MS

https://www.brainwork.md/content/uploads/2020/09/Brainwork-How-to-promote-remyelination-in-MS.png 2846 1601 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 18th September 2020 18th September 2020

Strategies to promote remyelination was a hot topic at this year’s virtual ACTRIMS/ECTRIMS joint meeting, with three expert presenters each addressing a different aspect of the subject, including the role…

Anne Carter, MA (Cantab)
0
0

17th September 2020

Does the microbiome have a role in MS?

https://www.brainwork.md/content/uploads/2020/09/MPR761-KSA-Content-Development-Brainwork-ECTRIMS-20200918_bacteria-article-2.png 2846 1600 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 17th September 2020 18th September 2020

Can the bacteria living in your gut influence multiple sclerosis (MS) susceptibility and risk of relapse? That was the question Emmanuelle Waubant (University of California, San Francisco, USA) posed during…

Anne Carter, MA (Cantab)
0
0

17th September 2020

Is disease-modifying treatment in primary progressive multiple sclerosis effective after all?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Is-disease-modifying-treatment-primary-progressive-multiplesclerosis-effective-after-all-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

Until now, several randomised controlled trials and real-world studies could not show the clinical benefit of disease‑modifying treatments (DMTs) in primary progressive multiple sclerosis (PPMS).1-4 However, some recently published results…

Anna Stelling, PhD
0
0

17th September 2020

Neurofilament light chain levels as a biomarker in multiple sclerosis

https://www.brainwork.md/content/uploads/2020/09/Brainwork-ECTRIMS-Neurofilament-light-chain-levels-as-a-biomarker-in-multiple-sclerosis-scaled.jpg 1703 2560 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 17th September 2020 18th September 2020

It has been previously shown that the neuronal cytoskeletal protein neurofilament light chain (NfL) is released into the blood and cerebrospinal fluid (CSF) upon neuroaxonal injury.1 Hence it was not…

Anna Stelling, PhD
0
0

17th September 2020

Do hormonal changes influence MS in women?

https://www.brainwork.md/content/uploads/2020/09/Brainwork-Do-hormonal-changes-influence-MS-in-women.jpg 2400 1600 Anne Carter, MA (Cantab) Anne Carter, MA (Cantab) https://secure.gravatar.com/avatar/8a0679fc29066255ffcb2a69eacf9ee3?s=96&d=mm&r=g 17th September 2020 23rd September 2020

There is a paradox in multiple sclerosis (MS): females appear to be more susceptible to the disease than males, but also have a better long-term prognosis. Could this be due…

Anne Carter, MA (Cantab)
0
0

31st August 2020

A reliable blood test for Alzheimer’s disease – is it becoming a reality?

https://www.brainwork.md/content/uploads/2020/08/Brainwork-Alzheimers-Dementia-Biomarkers-1024x683.jpg 1024 683 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 31st August 2020 31st August 2020

The increasing number of patients suffering from dementia caused by Alzheimer’s disease (AD) is a significant challenge for society and requires action by healthcare professionals and researchers worldwide. One important…

Anna Stelling, PhD
0
0

25th August 2020

Speaking to Prof. Günther Deuschl – “The world is not a world of competitors, it is a world of collaborators.“

https://www.brainwork.md/content/uploads/2020/08/Deuschl-20201-.jpg 1041 1092 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 25th August 2020 25th August 2020

Even now, after having retired, Prof. Günther Deuschl’s ultimate goal is to cure patients. As an expert in movement disorders, he has contributed to this field substantially during his career.…

Anna Stelling, PhD
0
0

18th August 2020

New evidence against fluoxetine in stroke recovery

https://www.brainwork.md/content/uploads/2020/08/Brainwork-Fluoxetine-Stroke-Recovery.jpg 5805 3875 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 18th August 2020 18th August 2020

Stroke is a very common disease that leads to disability in around half of its survivors.1 It has been believed that fluoxetine, a selective serotonin-reuptake inhibitor (SSRI), could improve neurological…

Anna Stelling, PhD
0
0

30th July 2020

Across specialties – a study on brain complications in COVID-19 patients

https://www.brainwork.md/content/uploads/2020/07/Brainwork-covid-head.jpg 5508 3672 Anna Stelling, PhD Anna Stelling, PhD https://secure.gravatar.com/avatar/03d32c6dd44674dd6ad1a82129cbc197?s=96&d=mm&r=g 30th July 2020 17th July 2020

Since December 2019, when clinicians first reported infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19), researchers have been trying to decipher the effects of the virus on…

Anna Stelling, PhD
0
0